July 21, 2009 – Clovis Oncology, a biotech startup based in Boulder, received $146.3 million in venture capital funding in the second quarter of 2009. According to the MoneyTree Report from PricewaterhouseCoopers LLP and the National Venture Capital Association based on data provided by Thomson Reuters, Clovis received more funding than any other company in the US during the quarter.
More info at http://www.bcbr.com/article.asp?id=101234